—
C+
C+ The full Closelook — membership. Open the C+ overview

Repligen Corporation (RGEN) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Repligen Corporation

RGEN in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Repligen designs equipment and consumables used to manufacture biological drugs: filtration systems, chromatography columns, resins, and instruments that monitor a bioprocess as it runs. It sells to biopharmaceutical makers, diagnostics companies and contract manufacturers that produce drugs on their behalf. The company is based in Waltham, Massachusetts, and lists in the United States.
Where it sits in the stack
Repligen sits outside our index and outside the Closelook build-out stack; it belongs to the healthcare sector, in the medical instruments and supplies industry, where it supplies tools for drug manufacturing rather than chip or data-centre infrastructure.
Who it is priced against
The comparison the market draws is with other bioprocessing-equipment suppliers, among them Sartorius, whose filtration and chromatography lines overlap with Repligen's own.
Why Closelook tracks it
Repligen holds a seat in the Russell 1000 but carries no Rubin or Halo index membership; it does not yet carry a Closelook score, and the diary has recorded no quotes or edition mentions for it.
What the diary watches
Whether order volumes from biopharmaceutical manufacturers pick up again after the post-pandemic slowdown in capital spending on bioprocessing equipment.

Repligen Corporation (RGEN) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for RGEN, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against RGEN on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Repligen Corporation (RGEN)?

Repligen Corporation trades as RGEN on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-19.

Is RGEN in a Closelook index?

Not currently — Repligen Corporation is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does RGEN trade against its moving averages?

Uptrend stack intact: Trades +9.9% vs the 50-day and +24.3% vs the 200-day average, 6.3% below the 52-week high and +75.2% off the 52-week low; a golden cross printed 27 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Repligen Corporation do?

Repligen designs equipment and consumables used to manufacture biological drugs: filtration systems, chromatography columns, resins, and instruments that monitor a bioprocess as it runs. It sells to biopharmaceutical makers, diagnostics companies and contract manufacturers that produce drugs on their behalf. The company is based in Waltham, Massachusetts, and lists in the United States. The comparison the market draws is with other bioprocessing-equipment suppliers, among them Sartorius, whose filtration and chromatography lines overlap with Repligen's own.

Where does Repligen Corporation sit in the AI build-out?

Repligen sits outside our index and outside the Closelook build-out stack; it belongs to the healthcare sector, in the medical instruments and supplies industry, where it supplies tools for drug manufacturing rather than chip or data-centre infrastructure. Repligen holds a seat in the Russell 1000 but carries no Rubin or Halo index membership; it does not yet carry a Closelook score, and the diary has recorded no quotes or edition mentions for it.

What does this page show?

A live price chart with SMA overlays and drawing tools for RGEN, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.